These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 466968

  • 21. [Effect of corglycon and cavinton on the hemodynamics of patients with initial manifestations of insufficiency of cerebral circulation].
    Ishchenko MM, Nechaĭ EE.
    Vrach Delo; 1988 May; (5):53-5. PubMed ID: 3420871
    [No Abstract] [Full Text] [Related]

  • 22. The effect of Cavinton on cerebrovascular resistance and its use in ophthalmological patients. A double-blind trial.
    Imre G, Németh B.
    Ther Hung; 1981 May; 29(3):120-3. PubMed ID: 7188137
    [No Abstract] [Full Text] [Related]

  • 23. [Effectiveness of using cavinton in patients of different ages with chronic forms of cerebrovascular diseases (clinico-rheographic research)].
    Burtsev EM, Shprakh VV, Savkov VS.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988 May; 88(1):39-44. PubMed ID: 3364094
    [Abstract] [Full Text] [Related]

  • 24. Comparative study of the clinical effects of vincamine + glycerol versus glycerol + placebo in the acute phase of stroke.
    Dekoninck WJ, Jocquet P, Jacquy J, Henriet M.
    Arzneimittelforschung; 1978 May; 28(9):1654-7. PubMed ID: 383107
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Controlled testing of vincamine with special reference to the flow properties of blood].
    Klein M, Szobor A, Bräuer H.
    Med Klin; 1979 Oct 24; Suppl():29-36. PubMed ID: 542163
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [The treatment of ischemic cerebral accidents with pervincamine].
    Warot P, Caron JC.
    Lille Med; 1971 Apr 24; 16():S 2:6l4-9. PubMed ID: 5162101
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [On the role of vincamine in the therapy of cerebrovascular diseases and impairment of cerebral function (author's transl)].
    Witzmann HK, Blechacz W.
    Arzneimittelforschung; 1977 Apr 24; 27(6a):1238-47. PubMed ID: 332190
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Therapeutic action of a combination of vincamine and piracetam in peripheral labyrinthine syndromes with a vascular component].
    Jiménez-Cervantes Nicolás JA, Ferrán Bernal J, Anula Suárez P, Gil Melgarejo JA.
    An Otorrinolaringol Ibero Am; 1981 Apr 24; 8(2):131-60. PubMed ID: 7270822
    [No Abstract] [Full Text] [Related]

  • 38. [Effect of piracetam on cerebral hemodynamics in patients with arteriosclerosis and dyscirculatory encephalopathy].
    Vesel'skiĭ ISh, Voroniuk MI.
    Klin Med (Mosk); 1986 Jun 24; 64(6):41-4. PubMed ID: 3747435
    [No Abstract] [Full Text] [Related]

  • 39. [Drug therapy in cerebral disorders. A double-blind study with Cetal retard in aged subjects].
    Schenker H.
    Med Klin; 1979 Oct 24; Suppl():48-50. PubMed ID: 542168
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.